Genetic variation in the serotonin 2A receptor and suicidal Ideation in a sample of 270 irish high-density schizophrenia families

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 150, Issue 3, 2009, Pages 411-417

  Fanous, Ayman H ^a,b,e   Chen, Xiangning ^a   Wang, Xu ^a   Amdur, Richard ^a   O'Neill, F Anthony ^c   Walsh, Dermot ^d   Kendler, Kenneth S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d HEALTH RESEARCH BOARD   (Ireland)

^e NONE   (United States)

Author keywords

Association; Polymorphism; Schizophrenia; Serotonin 2a; Suicide

Indexed keywords

HISTIDINE; SEROTONIN 2A RECEPTOR; TYROSINE;

ARTICLE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC VARIABILITY; HAPLOTYPE; HAPLOTYPE MAP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUICIDAL IDEATION;

EID: 63449111837     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30833     Document Type: Article

References (45)

1. Abdolmaleky HM, Faraone SV, Glatt SJ, Tsuang MT. 2004. Meta-analysis of association between the T102C polymorphism of the 5HT2a receptor gene and schizophrenia. Schizophr Res 67:53-62.
2. Arango V, Ernsberger P, Marzuk PM, Chen JS, Tierney H, Stanley M, Reis DJ, Mann JJ. 1990. Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims. Arch Gen Psychiatry 47:1038-1047.
3. Arias B, Gasto C, Catalan R, Gutierrez B, Pintor L, Fananas L. 2001. The 5-HT(2A) receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients. Am J Med Genet 105:801-804.
4. Asberg M, Traskman L, Thoren P. 1976. 5-HIAA in the cerebrospinal fluid. A. biochemical suicide predictor? Arch Gen Psychiatry 33:1193-1197.
5. Baritaki S, Rizos E, Zafiropoulos A, Soufla G, Katsafouros K, Gourvas V, Spandidos DA. 2004. Association between schizophrenia and DRD3 or HTR2 receptor gene variants. Eur J Hum Genet 12:535-541.
6. Barrett JC, Fry B, Mailer J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
7. Biver F, Wilder D, Lotstra F, Damhaut P, Goldman S, Mendlewicz J. 1997. Serotonin 5-HT2 receptor imaging in major depression: Focal changes in orbito-insular cortex. Br J Psychiatry 171:444-448.
8. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. 2005. Efficiency and power in genetic association studies. Nat Genet 37:1217-1223.
9. DeRosse P, Funke B, Burdick KE, Lencz T, Ekholm JM, Kane JM Kucher-lapati R, Malhotra AK. 2006. Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry 163:532-534.
10. Du L, Bakish D, Lapierre YD, Ravindran AV, Hrdina PD. 2000. Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet 96:56-60.
11. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplo-types. Genet Epidemiol 25:115-121.
12. Erdmann J, Shimron-Abarbanell D, Rietschel M, Albus M, Maier W, Korner J, Bondy B, Chen K, Shih JC, Knapp M, Propping P, Nothen MM. 1996. Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: Identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet 97:614-619.
13. Fanous AH, Kendler KS. 2005. Genetic heterogeneity, modifier genes, and quantitative phenotypes in psychiatric illness: Searching for a framework. Mol Psychiatry 10:6-13.
14. Fanous AH, Prescott CA, Kendler KS. 2004. The prediction ofthoughts of death or self-harm in a population-based sample of female twins. Psychol Med 34:301-312.
15. Fanous AH, Van Den Oord EJ, Riley BP, Aggen SH, Neale MC, O'Neill FA, Walsh D, Kendler KS. 2005. Relationship between a high-risk haplotype in the DTNBP1 (Dysbindin) gene and clinical features of schizophrenia. Am J Psychiatry 162:1824-1832.
16. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D. 2002. The structure of haplotype blocks in the human genome. Science 296:2225-2229.
17. Gibbons RD, Hur K, Bhaumik DK, Mann JJ. 2005. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 62:165-172.
18. Glennon RA, Titeler M, McKenney JD. 1984. Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sci 35:2505-2511.
19. Inayama Y, Yoneda H, Sakai T, Ishida T, Nonomura Y, Kono Y, Takahata R, Koh J, Sakai J, Takai A, Inada Y, Asaba H. 1996. Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am J Med Genet 67:103-105.
20. Kendler KS, O'Neill FA, Burke J, Murphy B, Duke F, Straub RE, Shinkwin R, Ni NM, MacLean CJ, Walsh D. 1996. Irish study on high-density schizophrenia families: Field methods and power to detect linkage. Am J Med Genet 67:179-190.
21. Laird NM, Horvath S, Xu X. 2000. Implementing a unified approach to family-based tests of association. Genet Epidemiol 19(Suppl 1):S36-S42.
22. D, Duan Y, He L. 2006. Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis. Biochem Biophys Res Commun 340:1006-1015.
23. Lieberman JA, Mailman RB, Duncan G, Sikich L, Chakos M, Nichols DE, Kraus JE. 1998. Serotonergic basis of antipsychotic drug effects in schizophrenia. Biol Psychiatry 44:1099-1117.
24. Livak KJ. 1999. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14:143-149.
25. Mann JJ, Stanley M, McBride PA, McEwen BS. 1986. Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43:954-959.
26. Manolio TA, Rodriguez LL, Brooks L, Abecasis G, Ballinger D, Daly M, Donnelly P, Faraone SV, Frazer K, Gabriel S, Gejman P, Guttmacher A, Harris EL, Insel T, Kelsoe JR, Lander E, McCowin N, Mailman MD, Nabel E, Ostell J, Pugh E, Sherry S, Sullivan PF, Thompson JF, Warram J, Wholley D, Milos PM, Collins FS. 2007. New models of collaboration in genome-wide association studies: The Genetic Association Information Network. Nat Genet 39:1045-1051.
27. Martin ER, Monks SA, Warren LL, Kaplan NL. 2000. A test for linkage and association in general pedigrees: The pedigree disequilibrium test. Am J Hum Genet 67:146-154.
28. Martin ER, Bass MP, Kaplan NL. 2001. Correcting for a potential bias in the pedigree disequilibrium test. Am J Hum Genet 68:1065-1067.
29. McGuffin P, Farmer A, Harvey I. 1991. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiatry 48:764-770.
30. McQueen MB, Devlin B, Faraone SV, Nimgaonkar VL, Sklar P, Smoller JW, Abou JR, Albus M, Bacanu SA, Baron M, Barrett TB, Berrettini W, Blacker D, Byerley W, Cichon S, Coryell W, Craddock N, Daly MJ, DePaulo JR, Edenberg HJ, Foroud T, Gill M, Gilliam TC, Hamshere M, Jones I, Jones L, Juo SH, Kelsoe JR, Lambert D, Lange C, Lerer B, Liu J, Maier W, Mackinnon JD, McInnis MG, McMahon FJ, Murphy DL, Nothen MM, Nurnberger JI, Pato CN, Pato MT, Potash JB, Propping P, Pulver AE, Rice JP, Rietschel M, Scheftner W, Schumacher J, Segurado R, Van Steen K, Xie W, Zandi PP, Laird NM. 2005. Combined analysis from eleven linkage studies of bipolar disorder provides strong evidence of susceptibility loci on chromosomes 6q and8q. Am J Hum Genet 77:582-595.
31. O'Connell JR, Weeks DE. 1998. PedCheck: A program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63:259-266.
32. Olfson M, Shaffer D, Marcus SC, Greenberg T. 2003. Relationship between antidepressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 60:978-982.
33. Owen MJ, Williams NM, O'Donovan MC. 2004. The molecular genetics of schizophrenia: New findings promise new insights. Mol Psychiatry 9:14-27.
34. Ozaki N, Rosenthal NE, Pesonen U, Lappalainen J, Feldman-Naim S, Schwartz PJ, Turner EH, Goldman D. 1996. Two naturally occurring amino acid substitutions of the 5-HT2A receptor: Similar prevalence in patients with seasonal affective disorder and controls. Biol Psychiatry 40:1267-1272.
35. Parsons MJ, D'Souza UM, Arranz MJ, Kerwin RW, Makoff AJ. 2004. The 1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol Psychiatry 56:406-410.
36. Ranade SS, Mansour H, Wood J, Chowdari KV, Brar LK, Kupfer DJ, Nimgaonkar VL. 2003. Linkage and association between serotonin 2A receptor gene polymorphisms and bipolar I disorder. Am J Med Genet Part B 121B:28-34.
37. Roy A, De Jong J, Linnoila M. 1989. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients. A 5-year follow-up study. Arch Gen Psychiatry 46:609-612.
38. Schulze TG, Ohlraun S, Czerski PM, Schumacher J, Kassem L, Deschner M, Gross M, Tullius M, Heidmann V, Kovalenko S, Jamra RA, Becker T, Leszczynska-Rodziewicz A, Hauser J, IlligT, Klopp N, WellekS, Cichon S, Henn FA, McMahon FJ, Maier W, Propping P, Nothen MM, Rietschel M. 2005. Genotype-phenotype studies in bipolar disorder showing association between the DAOA/G30 locus and persecutory delusions: A first step toward a molecular genetic classification of psychiatric phenotypes. Am J Psychiatry 162:2101-2108.
39. Spitzer RL, Williams JB, Gibbon J. 1987. Structured Clinical Interview for DSM-III-R Patient Version.
40. Van Den Oord EJ, Jiang Y, Riley BP, Kendler KS, Chen X. 2003. FP-TDI SNP scoring by manual and statistical procedures: A study oferror rates and types. Biotechniques 34:610-620, 622.
41. Warren JT Jr, Peacock ML, Rodriguez LC, Fink JK. 1993. An MspI
42. polymorphism in the hyman serotonin receptor gene (HTR2): Detection by DGGE and RFLP analysis. Hum Mol Genet 2:338.
43. Williams J, Spurlock G, McGuffin P, Mallet J, Nothen MM, Gill M, Aschauer H, Nylander PO, Macciardi F, Owen MJ. 1996. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryp-tamine type 2a-receptor gene. European Multicentre Association Study of Schizophrenia (EMASS) Group. Lancet 347:1294-1296.
44. Yatham LN, Liddle PF, Shiah IS, Scarrow G, Lam RW, Adam MJ, Zis AP, Ruth TJ. 2000. Brain serotonin2 receptors in major depression: A positron emission tomography study. Arch Gen Psychiatry 57:850-858.
45. Zhang K, Calabrese P, Nordborg M, Sun F. 2002. Haplotype block structure and its applications to association studies: Power and study designs. Am J Hum Genet 71:1386-1394.